Genetics: advances in genetic testing for deafness : Current Opinion in Pediatrics

Secondary Logo

Journal Logo

GENETICS: Edited by Nathaniel H. Robin


advances in genetic testing for deafness

Shearer, A. Eliota,b; Smith, Richard J.H.a,b,c

Author Information
Current Opinion in Pediatrics 24(6):p 679-686, December 2012. | DOI: 10.1097/MOP.0b013e3283588f5e


Purpose of review 

To provide an update on recently discovered human deafness genes and to describe advances in comprehensive genetic testing platforms for deafness, both of which have been enabled by new massively parallel sequencing technologies.

Recent findings 

Over the review period, three syndromic and six nonsyndromic deafness genes have been discovered, bringing the total number of nonsyndromic deafness genes to 64. Four studies have shown the utility of massively parallel sequencing for comprehensive genetic testing for deafness. Three of these platforms have been released on a clinical or commercial basis.


Deafness is the most common sensory deficit in humans. Genetic diagnosis has traditionally been difficult due to extreme genetic heterogeneity and a lack of phenotypic variability. For these reasons, comprehensive genetic screening platforms have been developed with the use of massively parallel sequencing. These technologies are also accelerating the pace of gene discovery for deafness. Because genetic diagnosis is the basis for molecular therapies, these advances lay the foundation for the clinical care of deaf and hard-of-hearing persons in the future.

© 2012 Lippincott Williams & Wilkins, Inc.

You can read the full text of this article if you:

Access through Ovid